Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.56 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.56 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | NSD2 | O96028 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL10492687 | 0.98 | PRSS1 (0.54) | PRSS1PRSS2PRSS3KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL2002135 | 0.98 | PRSS1 (0.54) | PRSS1PRSS2PRSS3KMT2AALDH1A1 | |
| SCHEMBL1450488 | 0.90 | PRSS1 (0.59) | PRSS1PRSS2PRSS3KMT2AALDH1A1 | |
| SCHEMBL43742 | 0.89 | KMT2A (0.61) | PRSS1PRSS2PRSS3KMT2AALDH1A1 | |
| SCHEMBL27659306 | 0.88 | PRSS1 (0.62) | PRSS1PRSS2PRSS3KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL320656 | 0.88 | PRSS1 (0.58) | PRSS1PRSS2PRSS3KMT2AALDH1A1 | |
| SCHEMBL27920690 | 0.88 | PRSS1 (0.58) | PRSS1PRSS2PRSS3KMT2AALDH1A1 | |
| SCHEMBL8517366 | 0.87 | PRSS1 (0.65) | PRSS1PRSS2PRSS3KMT2AALDH1A1 | |
| SCHEMBL30593894 | 0.86 | KMT2A (0.59) | PRSS1PRSS2PRSS3KMT2AALDH1A1 | |
| Bromide SCHEMBL11186851 | 0.85 | PRSS1 (0.63) | PRSS1PRSS2PRSS3KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250000832-A1 | ENHANCED NITRATE, ELEMENTAL METAL, AND AMINO ACID COMPOSITIONS AND METHODS OF USE | THERMOLIFE INT LLC (US) | 2025-01-02 | — | — | US | claimed |
| EP-4304389-A1 | ENHANCED NITRATE, ELEMENTAL METAL, AND AMINO ACID COMPOSITIONS AND METHODS OF USE | Thermolife International, LLC (US) | 2024-01-17 | — | — | EP | claimed |
| WO-2022192743-A1 | ENHANCED NITRATE, ELEMENTAL METAL, AND AMINO ACID COMPOSITIONS AND METHODS OF USE | THERMOLIFE INTERNATIONAL, LLC (US) | 2022-09-15 | — | — | WO | claimed |
| US-10736916-B1 | Methods of improving athletic performance with inorganic nitrate compositions | THERMOLIFE INTERNATIONAL, LLC (US) | 2020-08-11 | — | — | US | claimed |
| CN-109097117-A | A kind of energy-saving and environment-friendly gasoline comburant and preparation method thereof | 杭州中齐新材料科技有限公司 | 2018-12-28 | — | — | CN | claimed |
| CN-108042811-A | For treating the conjugate of the disease as caused by PSMA expression cells | 恩多塞特公司 | 2018-05-18 | — | — | CN | claimed |
| CN-104768381-B | Herbicidal combinations comprising chlorine Fampridine acid and bentazone | 美国陶氏益农公司 | 2017-10-31 | — | — | CN | claimed |
| CN-104768376-B | Herbicidal composition comprising aminopyralid and propanil | 美国陶氏益农公司 | 2017-05-17 | — | — | CN | claimed |
| CN-104797247-A | Conjugates for treating diseases caused by PSMA-expressing cells | ENDOCYTE INC | 2015-07-22 | — | — | CN | claimed |
| CN-102977098-B | Aryl-substituted indolizine derivative and preparation method and applications thereof | UNIV SHAOXING | 2015-04-01 | — | — | CN | claimed |
| CN-102008459-B | Antibacterial agents | BIOTA SCIENT MAN | 2013-05-29 | — | — | CN | claimed |
| CN-102977098-A | Aryl-substituted indolizine derivative and preparation method and applications thereof | UNIV SHAOXING | 2013-03-20 | — | — | CN | claimed |
| CN-101857551-A | Preparation method of o-aminoemthylbenzeneacetic acid (intermediate of ceforanide) | JINTAN SANFANG MEDICINE RAW MATERIAL CO LTD | 2010-10-13 | — | — | CN | claimed |
| CN-101380317-A | Pharmaceutical composition for relieving pruritus | CAYMAN ISLAND SHANGANSHENG DEV (CN) | 2009-03-11 | — | — | CN | claimed |
| EP-0550866-B1 | Process for the preparation of vinyl-substituted aromatics from arylamines | HOECHST AG (DE) | 1996-10-09 | — | — | EP | claimed |
| US-5475176-A | Process for preparing vinyl-substituted aromatic compounds from arylamines | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-12-12 | — | — | US | claimed |
| CN-1029932-C | Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers | BIORESEARCH INC (US) | 1995-10-11 | — | — | CN | claimed |
| CN-1088908-A | The chemical process of preparation 2-(2-aminomethyl phenyl)-3-methoxy-methyl acrylate | ZENECA LTD (GB) | 1994-07-06 | — | — | CN | claimed |
| EP-0550866-A2 | Process for the preparation of vinyl-substituted aromatics from arylamines | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-07-14 | — | — | EP | claimed |
| US-20250222143-A1 | TARGETED RADIOTHERANOSTICS BASED ON POLYAZAMACROCYCLIC, MIXED-DONOR SCAFFOLDS LINKED TO A TARGETING VECTOR | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2025-07-10 | — | — | US | disclosed |
| US-20250205372-A1 | RADIOPHARMACEUTICAL COMPOSITIONS, SYNTHETIC METHODS, AND METHODS OF TREATMENT | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2025-06-26 | — | — | US | disclosed |
| US-12194023-B2 | Compositions and methods for modular control of bioorthogonal ligation | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2025-01-14 | — | — | US | disclosed |
| EP-3736275-B1 | OXABICYCLOHEPTANE PRODRUGS FOR USE IN TREATING CANCER | LIXTE BIOTECHNOLOGY INC (US) | 2024-07-03 | — | — | EP | disclosed |
| US-11866444-B2 | Oxabicycloheptane prodrugs | LIXTE BIOTECHNOLOGY, INC. (US) | 2024-01-09 | — | — | US | disclosed |
| WO-2023178313-A2 | RADIOPHARMACEUTICAL COMPOSITIONS, SYNTHETIC METHODS, AND METHODS OF TREATMENT | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2023-09-21 | — | — | WO | disclosed |
| WO-2023070004-A1 | TARGETED RADIOTHERANOSTICS BASED ON POLYAZAMACROCYCLIC, MIXED-DONOR SCAFFOLDS LINKED TO A TARGETING VECTOR | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2023-04-27 | — | — | WO | disclosed |
| US-20220235066-A1 | OXABICYCLOHEPTANE PRODRUGS | LIXTE BIOTECHNOLOGY, INC. | 2022-07-28 | — | — | US | disclosed |
| US-20220218661-A1 | COMPOSITIONS AND METHODS FOR MODULAR CONTROL OF BIOORTHOGONAL LIGATION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2022-07-14 | — | — | US | disclosed |
| US-11236102-B2 | Oxabicycloheptane prodrugs | LIXTE BIOTECHNOLOGY, INC. (US) | 2022-02-01 | — | — | US | disclosed |
| US-20210276971-A1 | TRIAZAMACROCYCLE-DERIVED CHELATOR COMPOSITIONS FOR COORDINATION OF IMAGING AND THERAPY METAL IONS AND METHODS OF USING SAME | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2021-09-09 | — | — | US | disclosed |
| CN-113150030-A | Oxabicycloheptane prodrugs | 莱克斯特生物技术公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-106279023-B | 3,4, 5-trisubstituted pyrazole compound, preparation method, pharmaceutical composition and application | 中国科学院上海药物研究所 | 2021-06-22 | — | — | CN | disclosed |
| CN-107708686-B | Oxabicycloheptane prodrugs | 莱克斯特生物技术公司 | 2021-02-19 | — | — | CN | disclosed |
| WO-2021001420-A1 | PRODRUGS OF MODULATORS OF THE NMDA RECEPTOR | H. LUNDBECK A/S (DK) | 2021-01-07 | — | — | WO | disclosed |
| EP-3736275-A1 | OXABICYCLOHEPTANE PRODRUGS FOR USE IN TREATING CANCER | Lixte Biotechnology, Inc. (US) | 2020-11-11 | — | — | EP | disclosed |
| US-20200325151-A1 | OXABICYCLOHEPTANE PRODRUGS | LIXTE BIOTECHNOLOGY, INC. | 2020-10-15 | — | — | US | disclosed |
| WO-2020113077-A9 | COMPOSITIONS AND METHODS FOR MODULAR CONTROL OF BIOORTHOGONAL LIGATION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020113077-A1 | COMPOSITIONS AND METHODS FOR MODULAR CONTROL OF BIOORTHOGONAL LIGATION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2020-06-04 | — | — | WO | disclosed |
| US-10618908-B2 | Oxabicycloheptane prodrugs | LIXTE BIOTECHNOLOGY, INC. (US) | 2020-04-14 | — | — | US | disclosed |
| EP-3294287-B1 | OXABICYCLOHEPTANE PRODRUGS | LIXTE BIOTECHNOLOGY INC (US) | 2020-04-08 | — | — | EP | disclosed |
| CN-106715690-B | Main-objective metal organic framework system | 联邦科学和工业研究组织 | 2019-10-18 | — | — | CN | disclosed |
| US-10364252-B2 | Oxabicycloheptane prodrugs | LIXTE BIOTECHNOLOGY, INC. (US) | 2019-07-30 | — | — | US | disclosed |
| CN-109843907-A | Recombinate Microcystin production | 新南创新有限公司 | 2019-06-04 | — | — | CN | disclosed |
| CN-105585601-B | Anti-aging skin external composition and preparation method thereof | 株式会社林原 | 2018-11-13 | — | — | CN | disclosed |
| US-20180244690-A1 | OXABICYCLOHEPTANE PRODRUGS | LIXTE BIOTECHNOLOGY, INC. (US) | 2018-08-30 | — | — | US | disclosed |
| US-9988394-B2 | Oxabicycloheptane prodrugs | LIXTE BIOTECHNOLOGY INC. (US) | 2018-06-05 | — | — | US | disclosed |
| CN-108042811-A | For treating the conjugate of the disease as caused by PSMA expression cells | 恩多塞特公司 | 2018-05-18 | — | — | CN | disclosed |
| EP-3319139-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR BATTERY, AND COMPOSITION | Fujifilm Corporation (JP) | 2018-05-09 | — | — | EP | disclosed |
| US-20180108492-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND COMPOSITION | FUJIFILM CORPORATION (JP) | 2018-04-19 | — | — | US | disclosed |
| US-20180108492-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND COMPOSITION | FUJIFILM CORPORATION (JP) | 2018-04-19 | — | — | US | disclosed |
| EP-3294287-A1 | OXABICYCLOHEPTANE PRODRUGS | Lixte Biotechnology, Inc. (US) | 2018-03-21 | — | — | EP | disclosed |
| CN-107708686-A | Oxabicycloheptane prodrugs | 莱克斯特生物技术公司 | 2018-02-16 | — | — | CN | disclosed |
| US-9872919-B2 | Prodrugs for selective anticancer therapy | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2018-01-23 | — | — | US | disclosed |
| CN-106715690-A | Host-guest metal organic framework systems | 联邦科学和工业研究组织 | 2017-05-24 | — | — | CN | disclosed |
| CN-104781295-B | Addition-fragmentation agents | 3M创新有限公司 | 2017-03-08 | — | — | CN | disclosed |
| CN-106279023-A | 3,4,5-tri-substituted pyrazolecarboxylic compounds, preparation method, pharmaceutical composition and purposes | 中国科学院上海药物研究所 | 2017-01-04 | — | — | CN | disclosed |
| WO-2016186963-A1 | OXABICYCLOHEPTANE PRODRUGS | LIXTE BIOTECHNOLOGY, INC. (US) | 2016-11-24 | — | — | WO | disclosed |
| US-20160333024-A1 | OXABICYCLOHEPTANE PRODRUGS | LIXTE BIOTECHNOLOGY, INC. (US) | 2016-11-17 | — | — | US | disclosed |
| US-20160184459-A1 | CANCER CELL SPECIFIC IMAGING PROBES AND METHODS OF USE | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2016-06-30 | — | — | US | disclosed |
| CN-105585601-A | Anti-aging skin external composition and preparation method thereof | HAYASHIBARA CO | 2016-05-18 | — | — | CN | disclosed |
| CN-104918603-A | Anti-aging skin external composition and preparation method thereof | HAYASHIBARA CO | 2015-09-16 | — | — | CN | disclosed |
| US-20150224208-A1 | NOVEL PRODRUGS FOR SELECTIVE ANTICANCER THERAPY | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2015-08-13 | — | — | US | disclosed |
| CN-104797247-A | Conjugates for treating diseases caused by PSMA-expressing cells | ENDOCYTE INC | 2015-07-22 | — | — | CN | disclosed |
| CN-102977098-B | Aryl-substituted indolizine derivative and preparation method and applications thereof | UNIV SHAOXING | 2015-04-01 | — | — | CN | disclosed |
| WO-2015021305-A1 | CANCER CELL SPECIFIC IMAGING PROBES AND METHODS OF USE | THE RESEARCH FOUNDATION FOR THE STATE UNIVERISTY OF NEW YORK (US) | 2015-02-12 | — | — | WO | disclosed |
| WO-2014047199-A1 | NOVEL PRODRUGS FOR SELECTIVE ANTICANCER THERAPY | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2014-03-27 | — | — | WO | disclosed |
| CN-103370063-A | Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules | IMMUNOMEDICS INC | 2013-10-23 | — | — | CN | disclosed |
| CN-102977098-A | Aryl-substituted indolizine derivative and preparation method and applications thereof | UNIV SHAOXING | 2013-03-20 | — | — | CN | disclosed |
| CN-102898442-A | Refinement method of ceforanide | HENAN ZHONGSHUAI PHARMA CEUTICAL SCI & TECH DEV CO LTD | 2013-01-30 | — | — | CN | disclosed |
| CN-1858931-B | Lithium rechargeable battery | SAMSUNG SDI CO LTD | 2012-05-30 | — | — | CN | disclosed |
| CN-101071280-B | Electrophotographic photoreceptor, and image forming apparatus and process cartridge using the same | RICOH CO LTD | 2012-05-16 | — | — | CN | disclosed |
| CN-102459265-A | Pyrimidine inhibitors of kinase activity | ABBOTT LAB | 2012-05-16 | — | — | CN | disclosed |
| CN-101941982-B | Novel preparation method of pharmaceutical ceforanide | SICHUAN IND INST ANTIBIOTICS CHINA NAT PHARMACEUTICAL GROUP CORP | 2012-03-14 | — | — | CN | disclosed |
| EP-2377579-A1 | Cyclic peptide CXCR4 antagonists | Eli Lilly and Company (US) | 2011-10-19 | — | — | EP | disclosed |
| WO-2011121077-A1 | MULTISENSOR ARRAY FOR DETECTION OF ANALYTES OR MIXTURES THEREOF IN GAS OR LIQUID PHASE | DANMARKS TEKNISKE UNIVERSITET (DK) | 2011-10-06 | — | — | WO | disclosed |
| EP-2160221-B1 | CYCLIC PEPTIDE CXCR4 ANTAGONISTS | LILLY CO ELI (US) | 2011-07-20 | — | — | EP | disclosed |
| CN-101458476-B | Corona charger, and process cartridge and image forming apparatus using same | RICOH CO LTD | 2011-05-18 | — | — | CN | disclosed |
| US-RE42274-E1 | Cyclic peptide CXCR4 antagonists | ELI LILLY AND COMPANY (US) | 2011-04-05 | — | — | US | disclosed |
| CN-101941982-A | Novel preparation method of pharmaceutical ceforanide | SICHUAN IND INST ANTIBIOTICS CHINA NAT PHARMACEUTICAL GROUP CORP | 2011-01-12 | — | — | CN | disclosed |
| CN-101380317-B | Pharmaceutical composition for relieving pruritus | CAYMAN ISLAND SHANGANSHENG DEV PHARMACEUTICAL CO LTD | 2010-12-08 | — | — | CN | disclosed |
| CN-101857551-A | Preparation method of o-aminoemthylbenzeneacetic acid (intermediate of ceforanide) | JINTAN SANFANG MEDICINE RAW MATERIAL CO LTD | 2010-10-13 | — | — | CN | disclosed |
| US-20100130409-A1 | CYCLIC PEPTIDE CXCR4 ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2010-05-27 | — | — | US | disclosed |
| US-7691813-B2 | Provided are lactam-cyclized peptide CXCR4 antagonists (g-coupled protein receptor inhibitors) and a ligand SDF-1 (stromal cell-derived factor-1) useful in the in the treatment of cancers, rheumatoid arthritis, pulmonary fibrosis, and HIV infection | ELI LILLY AND COMPANY (US) | 2010-04-06 | — | — | US | disclosed |
| EP-2160221-A1 | CYCLIC PEPTIDE CXCR4 ANTAGONISTS | Eli Lilly & Company (US) | 2010-03-10 | — | — | EP | disclosed |
| CN-101458476-A | Corona charger, and process cartridge and image forming apparatus using same | RICOH KK (JP) | 2009-06-17 | — | — | CN | disclosed |
| CN-101380317-A | Pharmaceutical composition for relieving pruritus | CAYMAN ISLAND SHANGANSHENG DEV (CN) | 2009-03-11 | — | — | CN | disclosed |
| WO-2008150689-A1 | CYCLIC PEPTIDE CXCR4 ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2008-12-11 | — | — | WO | disclosed |
| US-20080300177-A1 | CYCLIC PEPTIDE CXCR4 ANTAGONISTS | ELI LILLY AND COMPANY | 2008-12-04 | — | — | US | disclosed |
| WO-2008010043-A2 | IMPROVED PROCESS FOR THE PREPARATION OF CEFORANIDE IN PURE FORM | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2008-01-24 | — | — | WO | disclosed |
| CN-101076330-A | Octahydropyrano [3, 4-C ] pyrroles as tachykinin receptor antagonists | MERCK & CO INC (US) | 2007-11-21 | — | — | CN | disclosed |
| CN-101071280-A | Electrophotographic photoreceptor, and image forming apparatus and process cartridge using the same | RICOH KK (JP) | 2007-11-14 | — | — | CN | disclosed |
| CN-101001860-A | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (CH) | 2007-07-18 | — | — | CN | disclosed |
| CN-1858931-A | Lithium rechargeable battery | SAMSUNG SDI CO LTD (KR) | 2006-11-08 | — | — | CN | disclosed |
| CN-1826325-A | 4,5-dihydro-imidazole as P2X7 ion channel blockers | AVENTIS PHARMA INC (US) | 2006-08-30 | — | — | CN | disclosed |
| CN-1787989-A | Imino ether derivative compound and medicine containing the same as active ingredient | ONO PHARMACEUTICAL CO (JP) | 2006-06-14 | — | — | CN | disclosed |
| CN-1202102-C | Method for the production of 2-coumarone and substituted 2-coumarones | DSM FINE CHEM AUSTRIA GMBH (AT) | 2005-05-18 | — | — | CN | disclosed |
| CN-1608061-A | Therapeutic isoquinoline compounds | ASTRAZENECA AB (SE) | 2005-04-20 | — | — | CN | disclosed |
| US-20040192707-A1 | Compounds and methods for the treatment or prevention of Flavivirus infections | VIROCHEM PHARMA INC. (CA) | 2004-09-30 | — | — | US | disclosed |
| WO-2004052879-A1 | THIOPHENEDERIVATIVES FOR THE TREATMENT OF FLAVIVIRUS INFECTIONS | VIROCHEM PHARMA INC. (CA) | 2004-06-24 | — | — | WO | disclosed |
| CN-1136197-C | Novel pyridajinone derivatives | - | 2004-01-28 | — | — | CN | disclosed |
| CN-1434815-A | Method for the production of 2-coumarone and substituted 2-coumarones | DSM FINE CHEM AUSTRIA GMBH (AT) | 2003-08-06 | — | — | CN | disclosed |
| US-6521211-B1 | Administering gases and ligand mixtures encapsulated in vesicles, scanning with ultrasonic frequency to oscillateand collapse the micelles, then detecting the reflected signals; medical diagnosis | BRISTOL-MYERS SQUIBB MEDICAL IMAGING, INC. | 2003-02-18 | — | — | US | disclosed |
| CN-1073109-C | Tetrahydrofuran antifungals | SCHERING CORP (US) | 2001-10-17 | — | — | CN | disclosed |
| CN-1238760-A | N- (aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions containing such compounds, and methods of inhibiting beta-amyloid peptide release and or synthesis using such compounds | ELAN PHARM INC (US) | 1999-12-15 | — | — | CN | disclosed |
| CN-1237960-A | N (aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and method for inhibiting 'beta'-amyloid peptide release and/or its synthesis by use of such compounds | YEELAN PHARMACEUTICAL CORP (US) | 1999-12-08 | — | — | CN | disclosed |
| CN-1040425-C | Chemical process | ZENECA LTD (GB) | 1998-10-28 | — | — | CN | disclosed |
| CN-1169426-A | Novel pyridajinone derivatives | HOFFMANN LA ROCHE (CH) | 1998-01-07 | — | — | CN | disclosed |
| CN-1161038-A | Tetrahydrofuran antifungals | SCHERING CORP (US) | 1997-10-01 | — | — | CN | disclosed |
| EP-0550866-B1 | Process for the preparation of vinyl-substituted aromatics from arylamines | HOECHST AG (DE) | 1996-10-09 | — | — | EP | disclosed |
| US-5541229-A | ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-07-30 | — | — | US | disclosed |
| US-5475176-A | Process for preparing vinyl-substituted aromatic compounds from arylamines | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-12-12 | — | — | US | disclosed |
| CN-1088908-A | The chemical process of preparation 2-(2-aminomethyl phenyl)-3-methoxy-methyl acrylate | ZENECA LTD (GB) | 1994-07-06 | — | — | CN | disclosed |
| EP-0550866-A2 | Process for the preparation of vinyl-substituted aromatics from arylamines | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-07-14 | — | — | EP | disclosed |
| EP-0550866-A2 | Process for the preparation of vinyl-substituted aromatics from arylamines | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (19 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160184459-A1 | CANCER CELL SPECIFIC IMAGING PROBES AND METHODS OF USE | OR10J3, CCR3, GPR3 | PRSS1 4430/4885PRSS2 4666/4885PRSS3 2978/4885 |
| US-20100130409-A1 | CYCLIC PEPTIDE CXCR4 ANTAGONISTS | CXCR4, CXCR1, CXCL12 | PRSS1 1175/4885PRSS2 2896/4885PRSS3 2926/4885 |
| US-20220218661-A1 | COMPOSITIONS AND METHODS FOR MODULAR CONTROL OF BIOORTHOGONAL LIGATION | CBR3, C1R, CBR1 | PRSS1 3886/4885PRSS2 4133/4885PRSS3 3189/4885 |
| US-20180108492-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND COMPOSITION | SCNN1A, CRY1, NR2E3 | PRSS1 1793/4885PRSS2 1869/4885PRSS3 1990/4885 |
| US-20250222143-A1 | TARGETED RADIOTHERANOSTICS BASED ON POLYAZAMACROCYCLIC, MIXED-DONOR SCAFFOLDS LINKED TO A TARGETING VECTOR | PAICS, RABGGTB, PARP1 | PRSS1 2512/4885PRSS2 4143/4885PRSS3 4504/4885 |
| US-20150224208-A1 | NOVEL PRODRUGS FOR SELECTIVE ANTICANCER THERAPY | NR4A3, ORC3, NTSR1 | PRSS1 3848/4885PRSS2 4138/4885PRSS3 2442/4885 |
| US-20220235066-A1 | OXABICYCLOHEPTANE PRODRUGS | UGT2B7, UGT1A6, UGT1A1 | PRSS1 3619/4885PRSS2 4639/4885PRSS3 4709/4885 |
| US-11866444-B2 | Oxabicycloheptane prodrugs | UGT2B7, UGT1A6, UGT1A1 | PRSS1 3619/4885PRSS2 4639/4885PRSS3 4709/4885 |
| US-12194023-B2 | Compositions and methods for modular control of bioorthogonal ligation | CBR3, C1R, CBR1 | PRSS1 3886/4885PRSS2 4133/4885PRSS3 3189/4885 |
| US-20200325151-A1 | OXABICYCLOHEPTANE PRODRUGS | UGT2B7, UGT1A6, UGT1A1 | PRSS1 3619/4885PRSS2 4639/4885PRSS3 4709/4885 |
| US-10618908-B2 | Oxabicycloheptane prodrugs | UGT2B7, UGT1A6, UGT1A1 | PRSS1 3619/4885PRSS2 4639/4885PRSS3 4709/4885 |
| US-20160333024-A1 | OXABICYCLOHEPTANE PRODRUGS | UGT2B7, UGT1A6, UGT1A1 | PRSS1 3619/4885PRSS2 4639/4885PRSS3 4709/4885 |
| US-20250205372-A1 | RADIOPHARMACEUTICAL COMPOSITIONS, SYNTHETIC METHODS, AND METHODS OF TREATMENT | QPCT, SSTR5, SSTR4 | PRSS1 3930/4885PRSS2 4531/4885PRSS3 4263/4885 |
| US-20210276971-A1 | TRIAZAMACROCYCLE-DERIVED CHELATOR COMPOSITIONS FOR COORDINATION OF IMAGING AND THERAPY METAL IONS AND METHODS OF USING SAME | PAICS, SLC39A14, SLC39A7 | PRSS1 4519/4885PRSS2 4728/4885PRSS3 4797/4885 |
| US-20080300177-A1 | CYCLIC PEPTIDE CXCR4 ANTAGONISTS | CXCR4, CXCR1, CXCL12 | PRSS1 1175/4885PRSS2 2896/4885PRSS3 2926/4885 |
| US-20040192707-A1 | Compounds and methods for the treatment or prevention of Flavivirus infections | ZC3HAV1, HAVCR2, MAVS | PRSS1 404/4885PRSS2 740/4885PRSS3 981/4885 |
| US-10364252-B2 | Oxabicycloheptane prodrugs | UGT2B7, UGT1A6, UGT1A1 | PRSS1 3619/4885PRSS2 4639/4885PRSS3 4709/4885 |
| US-11236102-B2 | Oxabicycloheptane prodrugs | UGT2B7, UGT1A6, UGT1A1 | PRSS1 3619/4885PRSS2 4639/4885PRSS3 4709/4885 |
| US-20180244690-A1 | OXABICYCLOHEPTANE PRODRUGS | UGT2B7, UGT1A6, UGT1A1 | PRSS1 3619/4885PRSS2 4639/4885PRSS3 4709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.